عنوان محتوای ارسال شده : The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China
ناشر : Cold Spring Harbor Laboratory
DOI کد :
10.1101/218859
سال انتشار : 2017
نویسنده : Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz
نوع : محتوای ارسال شده

@incollection{1, doi = {10.1101/218859}, url = {http://dx.doi.org/10.1101/218859}, year = 2017, publisher = {Cold Spring Harbor Laboratory}, pages = {}, author = {Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz}, title = {The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China} }
TY - DATA DO - 10.1101/218859 UR - http://dx.doi.org/10.1101/218859 TI - The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China PY - 2017 PB - Cold Spring Harbor Laboratory SP - AU -Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz
Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz, T. (2017). The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China. doi:10.1101/218859
“The Impact of 2017 ACC/AHA Guidelines on the Prevalence of Hypertension and Eligibility for Anti-Hypertensive Therapy in the United States and China.” (2017) - Author: Rohan Khera, Yuan Lu, Anshul Saxena, Khurram Nasir, Harlan M. Krumholz